Futura Medical (FUM)

London
29.57
-0.35(-1.18%)
  • Volume:
    14,306
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    29.20 - 29.20

FUM Overview

Prev. Close
29.55
Day's Range
29.2-29.2
Revenue
-
Open
29.2
52 wk Range
24-48.6
EPS
-0.02
Volume
14,306
Market Cap
84.97M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
376,562
P/E Ratio
-
Beta
3.25
1-Year Change
-31.6%
Shares Outstanding
287,296,527
Next Earnings Date
26 Sept 2022
What is your sentiment on Futura?
or
Market is currently closed. Voting is open during market hours.

Futura Medical Analysis

  • Daily Market News

    EU Market OpenAcross European open markets opened up positively with the FTSE 100 up 1.54% and DAX up 1.78% after further easing from ECB, oil prices rise higher, and US jobless...

Futura Medical Company Profile

Futura Medical Company Profile

Employees
11

Futura Medical plc is a United Kingdom-based pharmaceutical company. The Company is focused on developing a portfolio of products based on its transdermal DermaSys technology. Its patented transdermal DermaSys technology provides rapid and targeted local delivery of medical treatments via the skin. The Company is engaged in developing a portfolio of products for therapeutic areas, such as sexual health, including erectile dysfunction, and pain relief. The Company's products include MED3000 and TPR100. The Company's lead product, MED3000, is a topical gel formulation treatment for erectile dysfunction (ED) through an evaporative mode of action. The Company has conducted a Phase III study using MED3000 in ED. TPR100 is a topical non-steroidal anti-inflammatory for the pain and inflammation associated with sprains, strains and bruises and soft tissue rheumatism.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsSellSellBuyStrong SellStrong Sell
SummaryStrong SellStrong SellNeutralStrong SellStrong Sell
  • Any news on why the EU Approval Certification is taking so long?
    0
    • covid restrictions apply and hampper testing facilities no doubt
      0
    • EU UK approval is in place. Now in the commercialisation phase.
      0
    • (LON:FUM) AGM Statement from the pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain. MED3000 CE mark approved for marketing in Europe and UK; Commercialisation of MED3000 continues at pace with China and South East Asia partnered and discussions for other countries ongoing;
      0
  • More positive news today
    1
    • will this not go up again until we see revenues start to come in, which could be months?
      0
      • I think 50-60p range until the next news comes in. Next news will be receiving the EU Approval Certificate which is due anytime in the next 6 weeks. Just be patient
        0
      • thanks, i bought in near the top so i am trying to work out where the bottom is to lower my average, but it looks like it could go back to the 40s. maybe i will get a bit more at 50
        0
      • Possibly may go into the late 40’s. Would be a good entry point if it goes. I can honestly see this up near £1 in the next few months. Time will tell. Good luck
        0
    • will pull back down
      0
      • why? any news?
        0
    • 100p soon! Buy!
      1
      • this is going to rise & rise !!
        0
        • no pun intended :)
          0
      • very positive about this company.
        2
        • Good idea on the erectile dysfunction gel
          1